和元生物 (688238.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(和元生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 59,574,128.09204,805,008.26136,994,292.3583,750,990.5330,791,377.00291,304,276.50215,328,296.57134,898,975.1173,116,236.08
 营业利润(元) -50,934,967.48-155,446,013.49-87,679,634.77-55,032,831.73-32,492,918.4841,708,050.9536,300,707.2922,259,570.8713,478,822.68
 利润总额(元) -50,916,764.65-155,603,609.01-87,648,982.37-55,022,799.82-32,494,681.1441,624,187.1236,316,818.3722,285,900.5713,505,151.73
 净利润(元) -42,298,770.28-127,813,694.42-71,004,439.21-44,681,180.87-31,806,061.9539,025,209.0433,914,132.4220,025,835.8112,069,474.76
 归属于母公司股东的净利润(元) -42,170,292.32-127,938,329.85-71,099,570.54-44,797,891.77-31,743,281.2639,025,209.0433,914,132.4220,025,835.8112,069,474.76
盈利能力:
 销售毛利率(%) -20.82-6.555.161.89-21.4644.4145.2047.6451.08
 销售净利率(%) -71.00-62.41-51.83-53.35-103.3013.4015.7514.8516.51
 净资产收益率(%) -2.03-6.05-3.32-2.10-1.49----
 总资产报酬率ROA(%) -2.03-6.75-4.03-2.55-1.52----
 投入资本回报率ROIC(%) -1.89-5.75-3.15-1.98-1.402.392.121.180.72
营运能力:
 存货周转率(次) 0.952.981.861.300.62----
 应收账款周转率(次) 0.922.791.951.240.51----
 总资产周转率(次) 0.020.080.060.030.01----
偿债能力:
 资产负债率(%) 21.5020.9419.1215.1214.4712.818.0915.6015.36
 股东权益比率(%) 78.5079.0680.8884.8885.5387.1991.9184.4084.64
 已获利息倍数(倍) 92.2510.618.046.866.76-0.52-0.84-1.07-4.24
 流动比率 2.642.953.998.569.737.8417.9920.1316.13
 速动比率 2.242.553.367.568.717.1416.5718.8515.13
发展能力:
 营业收入增长率(%) 93.48-29.69-36.38-37.92-57.8914.2631.3436.2456.85
 营业利润增长率(%) -56.76-472.70-341.54-347.23-341.07-31.4011.8627.7123.10
 税后利润增长率(%) -32.85-425.90-309.65-323.70-363.00-28.0716.6929.6528.78
 净资产增长率(%) -5.89-5.22-1.94-0.620.51136.60143.51146.59-
 总资产增长率(%) 2.544.2911.43-1.18-0.5397.09111.00143.09-

前瞻产业研究院